Cathie Wood's Strategy: Investing in Discounted Growth Stocks

Amidst a volatile market, renowned growth investor Cathie Wood has been strategically picking up shares of companies that she believes are undervalued after their stock prices have taken a hit. Rather than shying away, Wood has been on the hunt for deals, scooping up additional shares of innovative companies with potential for significant long-term growth.

Shopify Inc. SHOP - Digital Commerce Dynamo

One company that has caught Wood's attention is Shopify Inc. SHOP. This Canadian-based enterprise provides an extensive commerce platform utilized globally, offering solutions in a variety of geographic territories including the US, UK, Australia, and parts of Latin America. With its headquarters nestled in Ottawa, Shopify continues to expand its reach, aiming to revolutionize the e-commerce sector by offering cutting-edge tools and services to businesses worldwide.

Adaptive Biotechnologies ADPT - Pioneering Immune Medicine

In the forefront of immune medicine, Adaptive Biotechnologies ADPT is making strides in the diagnosis and treatment of diseases through its groundbreaking platform. With its commercial-stage development in full swing, the Seattle-based company is pioneering efforts to understand the immune system and leverage this knowledge for medical advancements, a prospect that has attracted the attention of investors like Wood.

Intellia Therapeutics, Inc. NTLA - Innovating Genome Editing

Intellia Therapeutics, Inc. NTLA, stationed in the biotech hub of Cambridge Massachusetts, is a genome editing company dedicated to creating transformative gene-based therapies. The company's focus on developing sophisticated and potentially curative treatments puts it on the cutting edge of scientific advancements in medicine, garnering interest from investors keeping an eye on the future of healthcare.

Shopify, AdaptiveBiotech, Intellia